No Data
No Data
Zhonghong Healthcare: 2024 Semi-Annual Report Summary
Zhonghong Healthcare: 2024 Semi-Annual Report
Zhonghong Medical (300981.SZ): a net loss of 325.299 million yuan in the first half of the year, turning around year-on-year.
On August 29, Gelonghui announced the semi-annual report for the first half of 2024, with revenue of 1.148 billion yuan, a year-on-year increase of 14.97%; net income attributable to shareholders of the listed company was 32.5299 million yuan, turning loss into profit year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -4.2721 million yuan; basic earnings per share was 0.0836 yuan.
China Red Medical (300981.SZ) released its performance for the first half of the year, turning losses into profits of 32.5299 million yuan.
Zhonghong Medical (300981.SZ) released its semi-annual report for 2024, with the company's revenue reaching 11.48...
Here's Why Zhonghong Pulin Medical Products (SZSE:300981) Can Manage Its Debt Despite Losing Money
China Red Medical (300981.SZ): The main customers of the Safety Infusion Division products are currently in the domestic market.
On July 30th, gelunhui, 中红医疗(300981.SZ), stated on the investor interaction platform that the company's safety infusion business unit mainly serves the domestic market, and is not greatly affected by the above-mentioned additional tariffs. The main measures taken by the company regarding rubber glove tariffs include: 1. Expanding markets - actively exploring non-U.S. markets, improving market share in other regions. Marketing methods are used to promote the independent brand, vigorously expand the domestic market, and diversify market risks; 2. Reducing costs, promoting digital construction, reducing energ 南湖区南都村卫生室y consumption, and strengthening cost advantages; 3.布.
No Data
No Data